Sign in

James Larkin

@jameslarkin13.bsky.social
1.5K followers 550 following 107 posts

Research interests: the marketing practices of the pharmaceutical & medical device industries, multimorbidity, out-of-pocket payments. RCSI Postdoctoral fellow www.researchgate.net/profile/James-…

PostsRepliesMedia
Reposted by James Larkin
Marita Hennessy @maritahennessy.bsky.social · 06/03/2026
Associations between pharmaceutical industry interactions with physicians and chronic nonmalignant pain management prescribing practices: a systematic review link.springer.com/article/10.1... Mohammed Gharbia, Lydia Iladiva, @frankmoriarty.bsky.social, Tom Fahey & @jameslarkin13.bsky.social
link.springer.com
Associations between pharmaceutical industry interactions with physicians and chronic nonmalignant pain management prescribing practices: a systematic review - Cost Effectiveness and Resource Allocati...
Cost Effectiveness and Resource Allocation - Chronic nonmalignant pain (CNMP) is commonly treated with opioids and other analgesics, yet prescribing carries risks and substantial costs. Promotional...
033
James Larkin @jameslarkin13.bsky.social · 20/11/2025
Our current systems for research assessment are narrow and flawed - @ginnybarbour.bsky.social @aimosinc.bsky.social #AIMOS2025
053
James Larkin @jameslarkin13.bsky.social · 19/11/2025
A key strategy of commercial actors is to influence and distort the evidence base relating to the harms of their products This is done through funding misleading industry-friendly science & through the active promotion of misinformation @markpetticrew.bsky.social @aimosinc.bsky.social #AIMOS2025
0103
James Larkin @jameslarkin13.bsky.social · 18/11/2025
"I'm not influenced." "My colleagues are influenced, but I'm not." "I have ties with all the, companies, so I'm not influenced by any.” Lisa Bero describing the ways people rationalise their conflicts of interest, opening the #AIMOS2025 conference @aimosinc.bsky.social
2289
Reposted by James Larkin
Emma Grundtvig Gram @emmagram.bsky.social · 08/10/2025
Misinformation about health is flooding social media, exposing the limits of current regulations and interventions. In this scoping review, we highlight key challenges and gaps in the current landscape: ebm.bmj.com/content/earl... @brookenickel.bsky.social @sydney.edu.au @ucph.bsky.social
ebm.bmj.com
Addressing misleading medical information on social media: a scoping review of current interventions
Background Misleading information about medical products on social media may cause overuse. Objectives Explore interventions targeting the problem of misleading medical information and marketing on s...
185
Reposted by James Larkin
Margaret McCartney @mgtmccartney.bsky.social · 26/09/2025
sign up sign up come along to our first event 31st october or add yourself to our mailing list for a streamed section of the day. it's going to be excellent. no sponsorship, independent, and amazing people are coming medicine.st-andrews.ac.uk/centreforevi...
medicine.st-andrews.ac.uk
The Centre for Evidence and Values
[et_pb_section fb_built=1 disabled_on=off|off|off admin_label=Header Image and Nav Box _builder_version=4.27.4 _module_preset=default background_color=#FFFFFF background_image=https://medicine.st-andr...
035
James Larkin @jameslarkin13.bsky.social · 23/09/2025
🚨Publication🚨 Grateful to be part of this publication with @mgtmccartney.bsky.social and colleagues Take home: lots of hormone replace therapy social media claims don't align with best practice recommendations. And lots of the posters have conflicts of interest. Full study: tinyurl.com/2rxpfwnr
tinyurl.com
Does online information about hormone replacement therapy (or menopause hormone therapy) reflect indications from the British National Formulary and guidance from the National Institute for Health and...
Objectives To describe: (1) the most visible information (from individuals or organisations) on UK social media regarding hormone replacement therapy (HRT)/menopause hormone treatment for menopause; (...
002
James Larkin @jameslarkin13.bsky.social · 12/09/2025
Less inequality = fewer problems @profkepickett.bsky.social lays our her vision for a good society at #SSM2025 @socsocmed.bsky.social
052
James Larkin @jameslarkin13.bsky.social · 11/09/2025
Research by alcohol industry funded organisations like DrinkAware often distorts health evidence In that context, Alice Thompson presents on alcohol industry funded research on drink spiking #SSM2025 @socsocmed.bsky.social @markpetticrew.bsky.social @maizie333.bsky.social @spidermaani.bsky.social
0100
Reposted by James Larkin
Human Rights Watch @hrw.org · 10/09/2025
There is nowhere safe to go in Gaza. Israeli forces have ordered thousands of Palestinians in Gaza City to evacuate as the military prepares another major assault. States should act to prevent genocide in Gaza and press Israel to reverse course.
58262
James Larkin @jameslarkin13.bsky.social · 10/09/2025
Do unhealthy commodity advertising restrictions affect energy consumption, have unintended effects and are there loopholes? Great presentation by @frankdv.bsky.social discussing his evaluation of the Bristol unhealthy commodity advertising restrictions #SSM2025 @socsocmed.bsky.social
031
James Larkin @jameslarkin13.bsky.social · 10/09/2025
“Advertising is one of most effective ways of promoting harmful commodity use” Excellent presentation by @michaelpdaly.bsky.social on what policy restrictions local authorities place on harmful commodity advertising, & what factors impede or facilitate these policies #SSM2025 @socsocmed.bsky.social
042
James Larkin @jameslarkin13.bsky.social · 15/08/2025
Pharmaceutical payments to general practices rose from £2.5 mill in 2015 to £7.5 mill in 2022. 54 companies made payments, but one company, Chiesi—marketing respiratory inhalers—accounted for >50% of payments since 2017 The payment growth and the dominance of one company raise concerns about bias
034
Reposted by James Larkin
Marita Hennessy @maritahennessy.bsky.social · 27/06/2025
"Patient Partnership Week has been sponsored by Abbott, Amgen, AstraZeneca & Novartis" www.patients-association.org.uk/news/patient... Our commentary on commercial influences on patient & public involvement ➡️ academic.oup.com/heapro/artic... @jameslarkin13.bsky.social @healthpromint.bsky.social
patients-association.org.uk
Patient Partnership Week 2025
We’ve launched Patient Partnership Week 2025! Find out more and book to attend our free webinars.
086
James Larkin @jameslarkin13.bsky.social · 20/06/2025
Yesterday the Dáil debated legislation to legally mandate public disclosure of payments from pharmaceutical & medical device company payments to healthcare professionals and healthcare organisations. It was refreshing to hear insightful contributions from government and opposition TDs thread: 1/4
121
James Larkin @jameslarkin13.bsky.social · 19/06/2025
Great to speak alongside Kath Sansom & Kieran Harkin in the Oireachtas audiovisual room, outlining the need for sunshine legislation: legally mandated public disclosure of payments from pharmaceutical and medical device company payments to healthcare professionals and healthcare organisations.
162
Reposted by James Larkin
Research Ireland @researchireland.ie · 09/06/2025
We are pleased to announce that applications are now open for the New Foundations Scheme. The scheme supports eligible researchers who intend to pursue research, networking or dissemination activities within and across the diversity of disciplines. Go to: researchireland.ie/funding/new-foundations/
Decorative Graphic
034
Reposted by James Larkin
James Larkin @jameslarkin13.bsky.social · 03/06/2025
On Saturday, the Irish Times published a piece I wrote asking whether Novo Nordisk should be funding children’s playgrounds. We need to ask if there are hidden costs to Novo Nordisk funding parts of our education and health systems, costs that may not be worth paying for. shorturl.at/erwpH
shorturl.at
Should the maker of Ozempic be funding children’s playgrounds in Ireland?
In 2023, Novo Nordisk was suspended by its own industry body in the UK for two years over its sponsorship of weight management courses for health professionals
078
James Larkin @jameslarkin13.bsky.social · 03/06/2025
On Saturday, the Irish Times published a piece I wrote asking whether Novo Nordisk should be funding children’s playgrounds. We need to ask if there are hidden costs to Novo Nordisk funding parts of our education and health systems, costs that may not be worth paying for. shorturl.at/erwpH
shorturl.at
Should the maker of Ozempic be funding children’s playgrounds in Ireland?
In 2023, Novo Nordisk was suspended by its own industry body in the UK for two years over its sponsorship of weight management courses for health professionals
078
James Larkin @jameslarkin13.bsky.social · 28/05/2025
Publication: We modelled the impact of post-2016 changes to prescription medicine co-payment charges and cost caps on out-of-pocket prescription expenditure Mean annual expenditure for medical card holders reduced from €117 to €55. For the DPS-group, it reduced from €719 to €555 shorturl.at/l7OAh
sciencedirect.com
Modelling the impact of changes to prescription medicine cost-sharing schemes among middle aged and older adults
To assess impacts of government changes to prescription medicine co-payments on individuals’ out-of-pocket expenditure.Participants were community-dwe…
111
Reposted by James Larkin
Hannah Forde @hannahforde.bsky.social · 27/05/2025
Funded PhD opportunity at the University of Liverpool to explore the mental health and environmental impacts of outdoor advertising, focusing on meat and dairy www.findaphd.com/phds/project...
findaphd.com
The psychology of outdoor advertising at University of Liverpool on FindAPhD.com
PhD Project - The psychology of outdoor advertising at University of Liverpool, listed on FindAPhD.com
035
Reposted by James Larkin
James Packard Love @jamielove.bsky.social · 19/05/2025
$1000 per day for risdiplam from Roche for treatment of SMA.
111
James Larkin @jameslarkin13.bsky.social · 19/05/2025
Strange that a pharmaceutical industry funded children's poster about intellectual property doesn't mention intellectual property's role in millions of deaths in the COVID pandemic and HIV/AIDS epidemic It's more focused on how IP helps companies "grow and fund further research" ‪@abpi.bsky.social‬
190
Reposted by James Larkin
Uplift Ireland @uplift.ie · 13/05/2025
Greyhound racing is a cruel industry where thousands of dogs are killed every year. It is an industry that only benefits the gambling companies and bookmakers. We are calling for a ban on cruel, unpopular Greyhound racing once and for all. #Speirgorm
my.uplift.ie
Ban Greyhound Racing now
I am calling on the Government to ban cruel Greyhound racing. Will you do the same?
075
James Larkin @jameslarkin13.bsky.social · 09/05/2025
Grateful to have gotten @researchireland.ie funding to conduct a study with Alcohol Forum Ireland exploring corporate influences on public health alcohol policy. @paulaleonard.bsky.social
151
Reposted by James Larkin
Shaun Lintern @shaunlintern.bsky.social · 20/04/2025
🚨 INVESTIGATION: Private clinics delivering NHS cataract surgery face investigation over claims they have artificially inflated costs for the taxpayer, performed unnecessary operations and incentivised high-street optometrists to refer patients to them: www.thetimes.com/article/245f...
thetimes.com
Private cataract clinics investigated while making millions from NHS
Health service bosses fear price inflation and unnecessary operations are costing the taxpayer. Now a fraud unit is getting involved
1613480
Reposted by James Larkin
Institute of Alcohol Studies @ias.org.uk · 08/04/2025
Spot the difference 🔎 Left: A Guinness ad near an Irish primary school before a complaint. Right: After the complaint - now Guinness 0.0. A dangerous loophole lets alcohol brands dodge ad restrictions by promoting zero-alcohol products. It's time to close it. Found by @jameslarkin13.bsky.social
01918
James Larkin @jameslarkin13.bsky.social · 04/04/2025
Pleased to play a part in this publication on Zero Alcohol in Ireland lnkd.in/eQgXv_pZ 0.0 alcohol is being used as a loophole to facilitate alcohol marketing near schools See images from my town Left: Guinness ad before I complained that it's within 200m of a school, Right: after I complained
24011
James Larkin @jameslarkin13.bsky.social · 03/04/2025
🚨Publication We assessed the impact of multimorbidity on out-of-pocket prescription medicine expenditure for all adults in Denmark Even in Denmark, with large government subsidies, people with multimorbidity are vulnerable to high prescription medicine expenditure shorturl.at/caQDW
sciencedirect.com
The association between multimorbidity and out-of-pocket expenditure for prescription medicines among adults in Denmark: A population-based register study
Multimorbidity, defined as two or more chronic conditions in an individual, is increasing in prevalence and is associated with polypharmacy. Polypharm…
100
James Larkin @jameslarkin13.bsky.social · 31/03/2025
Proud to have supported this letter to @rthonwesstreeting.bsky.social The UK (& Ireland) need a conflict of interest disclosure system detailing the payments that pharmaceutical & medical device companies make to healthcare professionals, healthcare organisations and patient organisations
132
Reposted by James Larkin
Marita Hennessy @maritahennessy.bsky.social · 26/03/2025
Looking through @easoobesity.bsky.social #ECO2025 list of sponsors - having diversity in pharma cos. appears to be #Obesity #COI mgt strategy in recent yrs* Also interesting to see Pronokal (Nestlé) back (can't claim lack of awareness this time www.bmj.com/content/380/...) eco2025.org?p=sponsors
eco2025.org
32nd European Congress on Obesity
32nd European Congress on Obesity
121
Reposted by James Larkin
Prof Samantha Thomas @docsamantha.bsky.social · 26/03/2025
The need to call out corporate corruption in health - The Lancet Excellent from Helen Walls @martinmckee.bsky.social and @dinabalabanova.bsky.social www.thelancet.com/journals/lan...
thelancet.com
The need to call out corporate corruption in health
The 2023 Lancet Series on the commercial determinants of health1 highlighted how commercial organisations shape health policies, both positively and negatively. Some negative actions, such as spreadin...
0165
Reposted by James Larkin
susmith.bsky.social @susmith.bsky.social · 22/03/2025
This publication led by James Larkin reports an analysis of out of pocket expenditure across the whole Danish population, supported by Anders Prior and his colleagues. www.sciencedirect.com/science/arti...
sciencedirect.com
The association between multimorbidity and out-of-pocket expenditure for prescription medicines among adults in Denmark: A population-based register study
Multimorbidity, defined as two or more chronic conditions in an individual, is increasing in prevalence and is associated with polypharmacy. Polypharm…
111
Reposted by James Larkin
James Larkin @jameslarkin13.bsky.social · 19/03/2025
📢Publication We examined almost every multi-centre RCT with an Irish centre & found big reporting issues 🔎only 27% of RCTs reported number of participants recruited in Ireland Huge €'s are devoted to Irish RCT infrastructure, yet levels of Irish involvement in RCTs aren't clear shorturl.at/9mmGk
sciencedirect.com
Shortcomings in reporting country-level participation in multicenter randomized controlled trials involving Ireland as a collaborating partner: a metaresearch study
Multi-center randomized controlled trials (RCTs) provide vital information about healthcare interventions. Reporting on country-level participation is…
165
James Larkin @jameslarkin13.bsky.social · 19/03/2025
📢Publication We examined almost every multi-centre RCT with an Irish centre & found big reporting issues 🔎only 27% of RCTs reported number of participants recruited in Ireland Huge €'s are devoted to Irish RCT infrastructure, yet levels of Irish involvement in RCTs aren't clear shorturl.at/9mmGk
sciencedirect.com
Shortcomings in reporting country-level participation in multicenter randomized controlled trials involving Ireland as a collaborating partner: a metaresearch study
Multi-center randomized controlled trials (RCTs) provide vital information about healthcare interventions. Reporting on country-level participation is…
165
James Larkin @jameslarkin13.bsky.social · 18/03/2025
“One official inside the European Commission reportedly summed up how things were looking during a recent meeting: industry had largely secured what they wanted” @irishtimes.com Jack Power Inside the pharma industry’s lobbying campaign to water down reforms www.irishtimes.com/politics/202...
irishtimes.com
Inside the pharma industry’s lobbying campaign to water down reforms
Pharma companies ‘disappointed’ in Government’s stance during EU negotiations
033
Reposted by James Larkin
Maebh Ní Fhallúin @maebhnif.bsky.social · 10/03/2025
"more than a third [of survey respondents said] they had avoided healthcare appointments or buying medicine in the past year due to cost concerns. To afford their healthcare, almost half had cut down on general expenses, 30% accessed savings and 22% reduced food spending." #NCDs
032
James Larkin @jameslarkin13.bsky.social · 09/03/2025
The 2023 disclosure of payments to patient organisations in Ireland
000
Reposted by James Larkin
Marita Hennessy @maritahennessy.bsky.social · 06/03/2025
Lists, by country, of financial & non-financial support from Eli Lilly to patient organisations (e.g. funding for 'disease awareness training for advocates' 😏) #COI #CDoH #Obesity www.lilly.com/eu/support-t... Ping @jameslarkin13.bsky.social
lilly.com
Support to European Patient Organisations
Lilly is committed to working with Europe-based patient advocacy organisations for the benefit of patients in a way that is true to the EFPIA Code of Practice and Lilly's integrity in business policy.
053
James Larkin @jameslarkin13.bsky.social · 05/03/2025
Novo Nordisk engaged in a “large-scale, misleading, intransparent, biased promotional campaign of a highly sought after weight management medication. This case revealed deep cultural issues within the company” Piotr Ozieranski speaking on Channel 4’s Dispatches www.channel4.com/programmes/s...
channel4.com
Skinny Jab Scandal: Dispatches
Dispatches investigates the skinny jab. Is patient safety being compromised?
133
James Larkin @jameslarkin13.bsky.social · 04/03/2025
Proud to see our study covered in the @irishtimes.com www.irishtimes.com/health/2025/...
irishtimes.com
People with chronic conditions forced to reduce basic living expenses to afford health costs, says study
Research from RCSI highlights financial difficulties facing those with chronic health conditions.
0115
Reposted by James Larkin
James Larkin @jameslarkin13.bsky.social · 03/03/2025
🔎 To afford healthcare, 46% of participants cut down on general expenses, 30% accessed savings & 22% reduced food spending 🔎 Choice experiment found that participants were more likely to skip hospital visits if experiencing financial constraints, while medication would be prioritised
112
Reposted by James Larkin
James Larkin @jameslarkin13.bsky.social · 03/03/2025
📢 PhD Publication Our survey & choice experiment showed that people in Ireland with chronic conditions are experiencing significant financial issues: 🔎Over a third said they avoided healthcare appointments or buying medicine in previous year due to cost bmcprimcare.biomedcentral.com/articles/10....
bmcprimcare.biomedcentral.com
How do people with multimorbidity prioritise healthcare when faced with tighter financial constraints? A national survey with a choice experiment component - BMC Primary Care
Background People with multimorbidity (i.e., two or more chronic conditions) experience increased out-of-pocket healthcare costs and are vulnerable to cost-related non-adherence to recommended treatme...
188
James Larkin @jameslarkin13.bsky.social · 03/03/2025
📢 PhD Publication Our survey & choice experiment showed that people in Ireland with chronic conditions are experiencing significant financial issues: 🔎Over a third said they avoided healthcare appointments or buying medicine in previous year due to cost bmcprimcare.biomedcentral.com/articles/10....
bmcprimcare.biomedcentral.com
How do people with multimorbidity prioritise healthcare when faced with tighter financial constraints? A national survey with a choice experiment component - BMC Primary Care
Background People with multimorbidity (i.e., two or more chronic conditions) experience increased out-of-pocket healthcare costs and are vulnerable to cost-related non-adherence to recommended treatme...
188
Reposted by James Larkin
James Larkin @jameslarkin13.bsky.social · 26/02/2025
The pharmaceutical industry rank 6th, spending €21.75 on EU lobbying. And this is likely to be a "substantial underestimate"
096
James Larkin @jameslarkin13.bsky.social · 27/02/2025
Risks of industry funding of universities: Erodes support for academic endeavours not seen as commercially valuable Corporate capture of universities' public-good mission Distracting academic attention away from policies prioritising human & ecological health publicpolicy.ie/papers/indus...
publicpolicy.ie
Industry Funding of Irish Universities - Public Policy
This policy paper explores private sector funding of higher education institutions in Ireland. Large corporations are providing financial support to Irish universities in multiple ways including suppo...
173
James Larkin @jameslarkin13.bsky.social · 26/02/2025
The pharmaceutical industry rank 6th, spending €21.75 on EU lobbying. And this is likely to be a "substantial underestimate"
096
James Larkin @jameslarkin13.bsky.social · 19/02/2025
RCSI department of general practice is hiring a Postdoctoral Researcher in Lung Cancer Screening @rcsi.bsky.social www.linkedin.com/jobs/view/41...
linkedin.com
Royal College of Surgeons (RCSI) hiring Postdoctoral Researcher - Lung Cancer Screening in Dublin, County Dublin, Ireland | LinkedIn
Posted 8:16:25 AM. Job Title: Postdoctoral Researcher - Lung Cancer ScreeningDepartment: General Practice…See this and similar jobs on LinkedIn.
000
Reposted by James Larkin
Deirdre Robertson @deirdrearobertson.bsky.social · 18/02/2025
We have a paid summer internship in the Behavioural Research Unit. Looking for final year undergraduate or masters students in psychology, economics or social policy. Enthusiasm for experiments a must!
034
James Larkin @jameslarkin13.bsky.social · 18/02/2025
“I have even been told to tone it down, and that this is how it is, and it’s a rite of passage. The fear of speaking out is huge, but I don’t accept that this is a rite of passage – it is a hiring choice.“ TCD PhD student @conorreddy95.bsky.social www.irishtimes.com/ireland/educ...
irishtimes.com
Crisis in academia: ‘I love research, but I don’t see any security or stability in it’
Lack of funding, precarious work and intense competition mean the once-revered job of lecturing has become less attractive as a viable long-term career
054